Table 1.
Fascia closure (n = 73) | No fascia closure (n = 286) | p | |
---|---|---|---|
Gender | 54 F/19 M | 225 F/61 M | 0.38 |
Age (years) | 44 ± 10 (range 21–64) | 43 ± 12 (range 21–75) | 0.48 |
BMI (at surgery) | 51 ± 9 (range 35–80) | 49 ± 7 (range 31–75) | 0.06 |
BMI (at follow-up) | 36 ± 8 (range 23–59) | 35 ± 7 (range 21–55) | 0.33 |
Smoking | 29 (39.7%) | 137 (47.9%) | 0.24 |
DM II | 29 (39.7%) | 105 (36.7%) | 0.68 |
Sleeve | 23 (31.5%) | 93 (32.5%) | 0.93 |
RYGB | 44 (60.3%) | 181 (63.2%) | |
Other | 6 (8.2%) | 12 (4.19%) | |
TsH | 27 (36.9%) | 97 (33.9%) | 0.58 |
ASA score | 0.79 | ||
II | 4 (5.5%) | 20 (7%) | |
III/IV | 69 (94.5%) | 266 (93%) | |
LOS (min) | 166 ± 64 (range 69–477) | 110 ± 55 (range 44–556) | < 0.001 |
LOHS (days) | 8 ± 2 (range 5–24) | 6 ± 2 (range 3–23) | < 0.001 |
Follow-up (months) | 81 ± 20 (range 38–119) | 27 ± 18 (range 9–105) | < 0.001 |
Early complications | 0.14 | ||
CD 0/I/II | 68 (93.2%) | 279 (96.9%) | |
CD III/IV | 5 (6.8%) | 9 (3.1%) | |
WHD | 0 | 8 (2.8%) | 0.17 |
EWL | 0.61 ± 0.23 (range 0.06–1.13) | 0.62 ± 0.24 (range − 0.60–1.62) | 0.77 |
F female, M male, BMI body mass index (kg/m2), DM II type II diabetes mellitus, RYGB Roux-en-Y gastric bypass, TsH trocar site hernia, ASA American Society of Anesthesiology, LOS length of surgery, LOHS length of hospital stay, CD Clavien-Dindo classification, WHD wound healing disorders